The bank upgraded shares of the German biotechnology firm to a buy rating from neutral.
Related Posts
Oil could plunge to $40 in 2025 if OPEC unwinds voluntary production cuts, analysts say
Many market watchers predicted a bearish year ahead for crude.
This wholesaler is still ripe for gains even after a 30% move, global strategist says
The money manager is also bullish on a ride share provider and a cybersecurity stock.
From nuclear to quantum computing, how Big Tech intends to power AI’s insatiable thirst for energy
A huge upswing in the number of data centers shows no signs of slowing down, prompting Big Tech to consider how best to power the […]